Shares of BIO-Key International fell sharply in morning trading, sliding 13.6% after the biometric authentication and identity access management company released its third-quarter 2026 financial results ahead of the market open.
The company reported quarterly revenue of $1.48 million, significantly below the $2.4 million consensus estimate. The headline loss per share was reported as -$4.01, far larger than the analyst forecast of -$0.35. Management said the unusually large EPS figure was heavily influenced by a non-cash deemed dividend of approximately $4.5 million associated with a warrant inducement transaction completed during the quarter.
Removing the non-cash item from the equation, BIO-Key's underlying net loss improved modestly. The adjusted net loss narrowed 8% year-over-year to $886,000, and gross margin widened to 90% from 77% in the year-ago period. Management attributed the margin expansion to strength in license fee revenue, which rose 39% and marked the company's third consecutive quarter of double-digit growth in that segment.
Despite the software gains, other revenue streams weakened materially. Hardware revenue plunged from $363,642 in the prior-year period to just $12,404 in Q3 2026. Service revenue also declined, falling 27%. Those declines left total revenue well short of market expectations and prevented software growth from offsetting the top-line shortfall.
CEO Mike DePasquale said, "our Q3'26 results reflect the building strength of our core software business," but investors focused on the magnitude of the revenue miss and the headline EPS distortion.
Market conditions added to the pressure. The NASDAQ Composite traded lower, down 0.5% as investors continued to digest a hotter-than-expected October consumer price index reading released earlier in the week. Headline inflation rose 0.4% month-over-month, above the 0.3% forecast, and the market was also awaiting the October producer price index report released this morning. Concerns about the possibility of further rate hikes into a December Federal Reserve meeting weighed on technology and small-cap stocks broadly.
Those factors, together with the steep revenue miss and an alarming headline EPS number even if distorted by a non-cash accounting item, exacerbated selling pressure. The stock's longer-term trend had already been weak, and a financial analytics tool flagged the company’s financial health as "weak performance." By the session referenced, shares were trading at $2.23, well above the 52-week low of $1.55 but far below the 52-week high of $10.70.
For investors and analysts focused on production, mix, and cash conversion, the quarter highlights a mixed picture: software license fees are growing and lifting margins, but severe drawdowns in hardware and services are suppressing total revenue and pressuring near-term financial performance. In the current rate-sensitive market environment, such top-line misses can drive disproportionately strong negative reactions among small-cap and technology-exposed names.